Forkhead box protein O3 suppresses uveal melanoma development by increasing the expression of Bcl‑2‑like protein 11 and cyclin‑dependent kinase inhibitor 1B

Yan,Fengxia; Liao,Rifang; Lin,Shaofen; Deng,Xianguo; Little,Peter J.; Zheng,Wenhua

doi:10.3892/mmr.2017.8215

Forkhead box protein O3 suppresses uveal melanoma development by increasing the expression of Bcl‑2‑like protein 11 and cyclin‑dependent kinase inhibitor 1B

Authors:
- Fengxia Yan
- Rifang Liao
- Shaofen Lin
- Xianguo Deng
- Peter J. Little
- Wenhua Zheng
View Affiliations

Affiliations: School of Pharmaceutical Sciences and State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat‑sen University, Guangzhou, Guangdong 510060, P.R. China, School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Woolloongabba, Queensland QLD 4102, Australia
Published online on: December 7, 2017 https://doi.org/10.3892/mmr.2017.8215
Pages: 3109-3114

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Forkhead box protein O3 (FoxO3a) is a forkhead box family transcription factor which serves an important role in a number of biological functions, including tumor growth. A previous study indicated that FoxO3a serves a role in insulin like growth factor‑induced growth, migration and invasion of uveal melanoma (UM) cells; however, whether FoxO3a is associated with the development and formation of UM remains unknown. In the present study, the role of FoxO3a in UM development and formation was investigated by modulating the expression of FoxO3a in a human UM cell line. The results of the present study demonstrated that FoxO3a overexpression in UM cells inhibited cell proliferation and promoted cellular apoptosis, leading to an accumulation of cells at the G1 cell cycle phase. Western blot analysis demonstrated that FoxO3a overexpression increased the transcription and protein expression of Bcl‑2‑like protein 11 and cyclin‑dependent kinase inhibitor 1B, and inhibited cyclin D1 transcription and expression. The opposite effects were observed when FoxO3a was knocked down in UM cells. The results of the present study indicated that FoxO3a may exhibit a negative role in UM development and formation, which is consistent with its role as a tumor suppressor.

View Figures

View References

1	Hu DN, Yu GP, McCormick SA, Schneider S and Finger PT: Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol. 140:612–617. 2005. View Article : Google Scholar : PubMed/NCBI
2	Damato B and Heimann H: Personalized treatment of uveal melanoma. Eye (Lond). 27:172–179. 2013. View Article : Google Scholar : PubMed/NCBI
3	Liu YC, Tsai CC, Lee FL, Lee SM and Kao SC: Mortality from uveal melanoma treated by enucleation -a 16-year survey in Taiwan. Acta Ophthalmol. 91:e583–e584. 2013. View Article : Google Scholar : PubMed/NCBI
4	Shoushtari AN and Carvajal RD: Treatment of uveal melanoma. Cancer Treat Res. 167:281–293. 2016. View Article : Google Scholar : PubMed/NCBI
5	Zhang X, Tang N, Hadden T and Rishi A: Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta. 1813:1978–1986. 2011. View Article : Google Scholar : PubMed/NCBI
6	Wang H, Quirion R, Little PJ, Cheng Y, Feng ZP, Sun HS, Xu JP and Zheng WH: Forkhead box O transcription factors as possible mediators in the development of major depression. Neuropharmacology. 99:527–537. 2015. View Article : Google Scholar : PubMed/NCBI
7	Zhu H: Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review). Oncol Rep. 32:1327–1334. 2014. View Article : Google Scholar : PubMed/NCBI
8	Shukla S, Shukla M, MacLennan GT, Fu P and Gupta S: Deregulation of FOXO3A during prostate cancer progression. Int J Oncol. 34:1613–1620. 2009.PubMed/NCBI
9	Fonseca EAI, Oliveira MA, Eichler R, Akamine EH, Carvalho MHC, Barbosa AM, Dekker RFH, Khaper N and Fortes ZB: Antitumor effect of metformin in breast cancer is associated with AMPK and FOXO3a activation. Cancer Res. 73:2013. View Article : Google Scholar
10	Obsil T and Obsilova V: Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene. 27:2263–2275. 2008. View Article : Google Scholar : PubMed/NCBI
11	Vogt PK, Jiang H and Aoki M: Triple layer control: Phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle. 4:908–913. 2005. View Article : Google Scholar : PubMed/NCBI
12	Wang H, Zhou X, Huang J, Mu N, Guo Z, Wen Q, Wang R, Chen S, Feng ZP and Zheng W: The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells. Psychopharmacology (Berl). 228:129–141. 2013. View Article : Google Scholar : PubMed/NCBI
13	Biggs WH, Meisenhelder J, Hunter T, Cavenee WK and Arden KC: Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. P Natl Acad Sci USA. 96:7421–7426. 1999. View Article : Google Scholar
14	Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
15	Tang ED, Nuñez G, Barr FG and Guan KL: Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem. 274:16741–16746. 1999. View Article : Google Scholar : PubMed/NCBI
16	Cui M, Huang Y, Zhao Y and Zheng J: Transcription factor FOXO3a mediates apoptosis in HIV-1-infected macrophages. J Immunol. 180:898–906. 2008. View Article : Google Scholar : PubMed/NCBI
17	Yan F, Liao R, Farhan M, Wang T, Chen J, Wang Z, Little PJ and Zheng W: Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells. Biomed Pharmacother. 84:1538–1550. 2016. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z, Miao L, Tothova Z, Horner JW, Carrasco DR, et al: FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 128:309–323. 2007. View Article : Google Scholar : PubMed/NCBI
20	Burgering BM and Kops GJ: Cell cycle and death control: Long live Forkheads. Trends Biochem Sci. 27:352–360. 2002. View Article : Google Scholar : PubMed/NCBI
21	Ning Y, Luo C, Ren K, Quan M and Cao J: FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxy1-5,4′-di-n-octyl genistein. Mol Med Rep. 9:1982–1988. 2014. View Article : Google Scholar : PubMed/NCBI
22	He LY, Wei X, Du L, Liu L, Xu F, Min J, Li C, Tao DD, Chen Q, Hu JB and Gong JP: Remarkably reduced expression of FoxO3a in metaplastic colorectum, primary colorectal cancer and liver metastasis. J Huazhong Univ Sci Technolog Med Sci. 33:205–211. 2013. View Article : Google Scholar : PubMed/NCBI
23	Lin CH, Chang CY, Lee KR, Lin HJ, Chen TH and Wan L: Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway. BMC Cancer. 15:9582015. View Article : Google Scholar : PubMed/NCBI
24	Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC, et al: ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol. 10:138–148. 2008. View Article : Google Scholar : PubMed/NCBI
25	Yang WS, Dolloff NG and El-Deiry WS: ERK and MDM2 prey on FOXO3a. Nat Cell Biol. 10:125–126. 2008. View Article : Google Scholar : PubMed/NCBI
26	Wang H, Zhang Q, Zhang L, Little PJ, Xie X, Meng Q, Ren Y, Zhou L, Gao G, Quirion R and Zheng W: Insulin-like growth factor-1 induces the phosphorylation of PRAS40 via the PI3K/Akt signaling pathway in PC12 cells. Neurosci Lett. 516:105–109. 2012. View Article : Google Scholar : PubMed/NCBI
27	Zhang K, Moran A, Holst J and Wang Q: PI3K/Akt signalling regulates leucine transport in prostate cancer. Bju Int. 116:34–35. 2015.
28	Matsuzaki H, Daitoku H, Hatta M, Tanaka K and Fukamizu A: Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci USA. 100:pp. 11285–11290. 2003; View Article : Google Scholar : PubMed/NCBI
29	Wen Q, Duan X, Liao R, Little P, Gao G, Jiang H, Lalit S, Quirion R and Zheng W: Characterization of intracellular translocation of Forkhead transcription factor O (FoxO) members induced by NGF in PC12 cells. Neurosci Lett. 498:31–36. 2011. View Article : Google Scholar : PubMed/NCBI
30	Myatt SS and Lam EW: The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859. 2007. View Article : Google Scholar : PubMed/NCBI